English
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#activesurveillance search results

dr_coops's profile picture. Urologic oncology & epi, focus on #prostatecancer @UCSFcancer @UCSFurology. GU Chief @SFVAMC. All views strictly personal. RT≠E. #🟦
Matt Cooperberg
@dr_coops
Sep 10

Why we still need to move past risk groups for #prostatecancer @nccn @AmerUrological @uroweb. The pt on the left is an easy candidate for #activesurveillance; the one on the right likely has metastatic disease.

dr_coops's tweet image. Why we still need to move past risk groups for #prostatecancer @nccn @AmerUrological @uroweb. The pt on the left is an easy candidate for #activesurveillance; the one on the right likely has metastatic disease.
10
13
66
14
8K
Nolazco_JI's profile picture. 👨🏽‍⚕️ SUO Urologic Oncology Fellow | @harvardmed 🏥 @BWHUrology @MGHUrology @DanaFarber 🌐 #Fulbright Scholar 👨🏽‍🎓 MMSCI Alumni @Harvard #UroSoMe 🇦🇷🇺🇲
José Ignacio Nolazco, MD, MMSc
 @Nolazco_JI
Jan 3, 2023

Editorial Commentary: Surgery: Urological Surgery 👉 𝐀𝐜𝐭𝐢𝐯𝐞 𝐬𝐮𝐫𝐯𝐞𝐢𝐥𝐥𝐚𝐧𝐜𝐞 𝐟𝐨𝐫 𝐜𝐨𝐦𝐩𝐥𝐞𝐱 𝐫𝐞𝐧𝐚𝐥 𝐜𝐲𝐬𝐭𝐬: 𝐢𝐬 𝐢𝐭 𝐭𝐢𝐦𝐞 𝐟𝐨𝐫 𝐈𝐈𝐈-𝐅 𝐚𝐧𝐝 𝐈𝐕-𝐅? PDF link: amj.amegroups.com/article/view/7… #activesurveillance #renalcysts #renalcancer #urology

Nolazco_JI's tweet image. Editorial Commentary: Surgery: Urological Surgery 👉 𝐀𝐜𝐭𝐢𝐯𝐞 𝐬𝐮𝐫𝐯𝐞𝐢𝐥𝐥𝐚𝐧𝐜𝐞 𝐟𝐨𝐫 𝐜𝐨𝐦𝐩𝐥𝐞𝐱 𝐫𝐞𝐧𝐚𝐥 𝐜𝐲𝐬𝐭𝐬: 𝐢𝐬 𝐢𝐭 𝐭𝐢𝐦𝐞 𝐟𝐨𝐫 𝐈𝐈𝐈-𝐅 𝐚𝐧𝐝 𝐈𝐕-𝐅? PDF link: amj.amegroups.com/article/view/7… #activesurveillance #renalcysts #renalcancer #urology
5
25
69
9
19K
dr_coops's profile picture. Urologic oncology & epi, focus on #prostatecancer @UCSFcancer @UCSFurology. GU Chief @SFVAMC. All views strictly personal. RT≠E. #🟦
Matt Cooperberg
@dr_coops
Jul 3

Great paper @EUplatinum confirming safety of #activesurveillance for #prostatecancer out to 25 years in the Göteborg-1 trial. dx.doi.org/10.1016/j.euru…

dr_coops's tweet image. Great paper @EUplatinum confirming safety of #activesurveillance for #prostatecancer out to 25 years in the Göteborg-1 trial. dx.doi.org/10.1016/j.euru…
2
23
92
21
6K
perryjxu's profile picture. Assistant Professor of Urology at Northwestern University #endourologist #holep #pcnl #urs #bph #kidneystones
Perry Xu
 @perryjxu
Sep 9

Grateful to present our collaborative work showing that in modern day, prostates can grow close to 5% per year in volume on serial MRI for patients with GG1 prostate cancer. Don’t forget to surveil for BPH! #bph #activesurveillance @NM_Urology @Endo_Society #wcet2025

perryjxu's tweet image. Grateful to present our collaborative work showing that in modern day, prostates can grow close to 5% per year in volume on serial MRI for patients with GG1 prostate cancer. Don’t forget to surveil for BPH! #bph #activesurveillance @NM_Urology @Endo_Society #wcet2025
2
2
19
0
2K
brookmans76's profile picture. Professor of Urology @LMU_Muenchen, SVP Therapeutic Area Head Urologic Oncology @AuraBiosciences - former VP R&D J&J - Sports Medicine 🚵‍♀️Passionate Cyclist
Sabine D. Brookman-May
 @brookmans76
Oct 28, 2023

Excellent review/MA: non-surgical interventions 5ARI, ARSI, exercise in #ProstateCancer #ActiveSurveillance 👉Risk of bias↗️ no reliable conclusions (yet) 👉Adding some more concerns: biopsy detection bias ➡️impact on PFS, next treatment subjectivity, possible rebound (ENACT)👇

brookmans76's tweet image. Excellent review/MA: non-surgical interventions 5ARI, ARSI, exercise in #ProstateCancer #ActiveSurveillance 👉Risk of bias↗️ no reliable conclusions (yet) 👉Adding some more concerns: biopsy detection bias ➡️impact on PFS, next treatment subjectivity, possible rebound (ENACT)👇
brookmans76's tweet image. Excellent review/MA: non-surgical interventions 5ARI, ARSI, exercise in #ProstateCancer #ActiveSurveillance 👉Risk of bias↗️ no reliable conclusions (yet) 👉Adding some more concerns: biopsy detection bias ➡️impact on PFS, next treatment subjectivity, possible rebound (ENACT)👇
1
14
41
3
6K
ProstateUK's profile picture. 1 in 8 men will get prostate cancer. We work to give every man the power to navigate it. #ProstateCancerUK
Prostate Cancer UK
 @ProstateUK
Aug 19

Meet Michael 👋 He might look familiar from our new TV advert - and his connection is personal. He was diagnosed with #ProstateCancer in 2020 and was on #ActiveSurveillance until early 2024, when he underwent surgery. #MensHealth

ProstateUK's tweet image. Meet Michael 👋 He might look familiar from our new TV advert - and his connection is personal. He was diagnosed with #ProstateCancer in 2020 and was on #ActiveSurveillance until early 2024, when he underwent surgery. #MensHealth
1
3
25
0
2K
HimanshuNagarMD's profile picture. Director of Genitourinary Program, Department of Radiation Oncology @MSKCancerCenter
Himanshu Nagar
@HimanshuNagarMD
Aug 24, 2024

#ActiveSurveillance for FIR #prostatecancer (caveats of dataset) increased to nearly 15% by 2020.

HimanshuNagarMD's tweet image. #ActiveSurveillance for FIR #prostatecancer (caveats of dataset) increased to nearly 15% by 2020.
JAMANetworkOpen's profile picture. JAMA Network Open is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
JAMA Network Open
 @JAMANetworkOpen
Aug 22, 2024

Active surveillance increased for patient with newly diagnosed intermediate-risk prostate cancer, 2010-2020, this study finds, particularly for patients older age, lower Gleason score, treatment at an academic center, higher education, and lower income. ja.ma/4dTW2SV

jamanetwork.com

Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer

This cohort study examines trends in the demographic and clinical characteristics of US men newly diagnosed with intermediate-risk prostate cancer whose treatment utilized active surveillance.

Source: jamanetwork.com
0
3
12
2
7K
0
8
34
0
4K
brookmans76's profile picture. Professor of Urology @LMU_Muenchen, SVP Therapeutic Area Head Urologic Oncology @AuraBiosciences - former VP R&D J&J - Sports Medicine 🚵‍♀️Passionate Cyclist
Sabine D. Brookman-May
 @brookmans76
Mar 12, 2023

How can we qualify men with GG2 #ProstateCancer for #ActiveSurveillance? Great talk by @dr_coops at #EAU23 outlining options to improve patient selection with clinical characteristics/CAPRA-Score -/+ additional genomic risk-classifiers (Decipher, Artera, Prolaris, Oncotype)

brookmans76's tweet image. How can we qualify men with GG2 #ProstateCancer for #ActiveSurveillance? Great talk by @dr_coops at #EAU23 outlining options to improve patient selection with clinical characteristics/CAPRA-Score -/+ additional genomic risk-classifiers (Decipher, Artera, Prolaris, Oncotype)
brookmans76's tweet image. How can we qualify men with GG2 #ProstateCancer for #ActiveSurveillance? Great talk by @dr_coops at #EAU23 outlining options to improve patient selection with clinical characteristics/CAPRA-Score -/+ additional genomic risk-classifiers (Decipher, Artera, Prolaris, Oncotype)
brookmans76's tweet image. How can we qualify men with GG2 #ProstateCancer for #ActiveSurveillance? Great talk by @dr_coops at #EAU23 outlining options to improve patient selection with clinical characteristics/CAPRA-Score -/+ additional genomic risk-classifiers (Decipher, Artera, Prolaris, Oncotype)
0
9
27
3
2K
arteraAI's profile picture. A leading precision medicine company, ArteraAI develops AI-enabled tests to help personalize therapy for cancer patients.
ArteraAI
 @arteraAI
Aug 15, 2024

For lower risk patients, choosing between active treatment or #activesurveillance is not an easy decision. Take a tour of Artera's sample test report and its #prognostic results to see how it can help clinicians and patients decide if active surveillance is a suitable option:

arteraAI's tweet image. For lower risk patients, choosing between active treatment or #activesurveillance is not an easy decision. Take a tour of Artera's sample test report and its #prognostic results to see how it can help clinicians and patients decide if active surveillance is a suitable option:
arteraAI's tweet image. For lower risk patients, choosing between active treatment or #activesurveillance is not an easy decision. Take a tour of Artera's sample test report and its #prognostic results to see how it can help clinicians and patients decide if active surveillance is a suitable option:
0
4
4
0
305
Adam_Weiner535's profile picture. @CedarsSinai + @UclaUrology @UroOnc ♋️🧬|Supporting editor @EUplatinum📝|Formerly: @NM_Urology @Uchipritzker @Yale ‘12| @abhita_reddy=No one can do it better❤️
Adam B. Weiner, MD
@Adam_Weiner535
Sep 27, 2023

Good to know! No MD has ever been successfully sued ⚖️ for promoting #activesurveillance for #prostatecancer (or any cancer) In fact, three lawsuits were related to "NOT" recommending AS @allenhomd @TimDaskivich @CedarsSinaiMed #PCSM @AnnalsofSurgery tinyurl.com/bdcm35np

Adam_Weiner535's tweet image. Good to know! No MD has ever been successfully sued ⚖️ for promoting #activesurveillance for #prostatecancer (or any cancer) In fact, three lawsuits were related to "NOT" recommending AS @allenhomd @TimDaskivich @CedarsSinaiMed #PCSM @AnnalsofSurgery tinyurl.com/bdcm35np
2
6
45
3
11K
clinicalthyroid's profile picture. A journal of the @AmThyroidAssn. Covers the latest clinical #thyroid research & issues. Editor: @DoctorAngell | CT for the Public: @thyroidfriends
Clinical Thyroidology
 @clinicalthyroid
Oct 5

Read the Latest Open Access in October! What happens to #PapillaryThyroidMicrocarcinoma under #ActiveSurveillance during #pregnancy? Commentary by Drs. @DrRoweEndo & Boelaert on data pub'd in @thyroidjournal ow.ly/F57X50X6j1o #thyroidcancer #thyroid #medtwitter #endotwitter

clinicalthyroid's tweet image. Read the Latest Open Access in October! What happens to #PapillaryThyroidMicrocarcinoma under #ActiveSurveillance during #pregnancy? Commentary by Drs. @DrRoweEndo & Boelaert on data pub'd in @thyroidjournal ow.ly/F57X50X6j1o #thyroidcancer #thyroid #medtwitter #endotwitter
0
0
6
1
469
RicBertolo's profile picture. Assistant Prof. of Urology @UniVerona || @ERUSRobotics, @SIU_Italia Research, @AgileGroupUro Member || @EAU_Uroonco Associate Editor || @Surgquest Urology Lead
𝙍𝙞𝙘𝙘𝙖𝙧𝙙𝙤 𝘽𝙚𝙧𝙩𝙤𝙡𝙤 MD PhD
 @RicBertolo
Jun 9, 2024

New study by our group published on @ejsotweets #PartialNephrectomy After a Period of #ActiveSurveillance: Are Perioperative and Pathology Outcomes Worsened Compared to Immediate Surgery? Read the #OpenAccess full text: 🔗 ejso.com/article/S0748-… Visual abstract below ⬇️

RicBertolo's tweet image. New study by our group published on @ejsotweets #PartialNephrectomy After a Period of #ActiveSurveillance: Are Perioperative and Pathology Outcomes Worsened Compared to Immediate Surgery? Read the #OpenAccess full text: 🔗 ejso.com/article/S0748-… Visual abstract below ⬇️
1
8
31
2
5K
DrYukselUrun's profile picture. Medical Oncologist, Prof.Dr. @AnkaraUni - Genitourinary Cancers - Believer in #Science #Diversity #Equity #Advocacy
Yüksel Ürün
@DrYukselUrun
Nov 21

Active surveillance for intermediate-risk prostate cancer rose from 5% in 2010 to 12% in 2020. Most common in GG1 cases (53.8% by 2020). PSA and GG remain key factors. @LoebStacy @JAMA_current #ProstateCancer #ActiveSurveillance #Oncology #CancerResearch @OncoAlert

DrYukselUrun's tweet image. Active surveillance for intermediate-risk prostate cancer rose from 5% in 2010 to 12% in 2020. Most common in GG1 cases (53.8% by 2020). PSA and GG remain key factors. @LoebStacy @JAMA_current #ProstateCancer #ActiveSurveillance #Oncology #CancerResearch @OncoAlert
0
20
54
8
4K
MUSICUrology's profile picture. Michigan Urological Surgery Improvement Collaborative (MUSIC), is a community of urology practices - 46 within Michigan and 4 outside of MI. Funded by @BCBSM
MUSIC Urology
@MUSICUrology
Jan 30

📢 This study explores barriers & facilitators in #activesurveillance care for low-risk #prostatecancer Findings highlight the need for team-based care, provider collaboration, psychosocial support & better EHR tools to improve AS adherence.

MUSICUrology's tweet image. 📢 This study explores barriers & facilitators in #activesurveillance care for low-risk #prostatecancer Findings highlight the need for team-based care, provider collaboration, psychosocial support & better EHR tools to improve AS adherence.
0
2
4
1
352
SFreedlandMD's profile picture. Editor Emeritus of @pcan_journal; Dir of CIRCL, studying effects of lifestyle choices on cancer risk and progression; AD Education/Training @CSCancerCare.
Stephen Freedland, MD
 @SFreedlandMD
Jun 1, 2024

RCT data: metformin does NOT benefit pts on #activesurveillance for #prostatecancer. In obese pts, pathological progression >2-fold more w/ metformin. Study rationale: observational data showing “benefits”. Association does not mean causation. This is why we need RCTs! #ASCO24

SFreedlandMD's tweet image. RCT data: metformin does NOT benefit pts on #activesurveillance for #prostatecancer. In obese pts, pathological progression >2-fold more w/ metformin. Study rationale: observational data showing “benefits”. Association does not mean causation. This is why we need RCTs! #ASCO24
SFreedlandMD's tweet image. RCT data: metformin does NOT benefit pts on #activesurveillance for #prostatecancer. In obese pts, pathological progression >2-fold more w/ metformin. Study rationale: observational data showing “benefits”. Association does not mean causation. This is why we need RCTs! #ASCO24
SFreedlandMD's tweet image. RCT data: metformin does NOT benefit pts on #activesurveillance for #prostatecancer. In obese pts, pathological progression >2-fold more w/ metformin. Study rationale: observational data showing “benefits”. Association does not mean causation. This is why we need RCTs! #ASCO24
SFreedlandMD's tweet image. RCT data: metformin does NOT benefit pts on #activesurveillance for #prostatecancer. In obese pts, pathological progression >2-fold more w/ metformin. Study rationale: observational data showing “benefits”. Association does not mean causation. This is why we need RCTs! #ASCO24
0
6
32
4
9K
MUSICUrology's profile picture. Michigan Urological Surgery Improvement Collaborative (MUSIC), is a community of urology practices - 46 within Michigan and 4 outside of MI. Funded by @BCBSM
MUSIC Urology
@MUSICUrology
May 9

Collaborative members discussed: 1. Who should be on #activesurveillance 2. Who should be LR v HR 3. How best to follow LR v HR 4. What else should we know about AS? What do you think? #Pca #QualityImprovement

MUSICUrology's tweet image. Collaborative members discussed: 1. Who should be on #activesurveillance 2. Who should be LR v HR 3. How best to follow LR v HR 4. What else should we know about AS? What do you think? #Pca #QualityImprovement
MUSICUrology's tweet image. Collaborative members discussed: 1. Who should be on #activesurveillance 2. Who should be LR v HR 3. How best to follow LR v HR 4. What else should we know about AS? What do you think? #Pca #QualityImprovement
MUSICUrology's tweet image. Collaborative members discussed: 1. Who should be on #activesurveillance 2. Who should be LR v HR 3. How best to follow LR v HR 4. What else should we know about AS? What do you think? #Pca #QualityImprovement
MUSICUrology's tweet image. Collaborative members discussed: 1. Who should be on #activesurveillance 2. Who should be LR v HR 3. How best to follow LR v HR 4. What else should we know about AS? What do you think? #Pca #QualityImprovement
0
2
8
0
842
Cacciamani_MD's profile picture. Assoc Prof @USC_Urology | Director of Lab @urology_AI | Chair @EAU_YAUroTech | PI @AI_PRISMA @CANGARU_check| Board @ESUI_uro @JUrology @UroAI_news | RT/RE≠E
Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺
@Cacciamani_MD
Feb 15, 2023

👁️💻 Cystic renal masses are common incidental findings on imaging 💡AS may be appropriate if accurate stratification 💰#RenalCysts #ceUS studied for #activeSurveillance cost-effectiveness compared to CT & MRI 👉tinyurl.com/mcu32ucx

Cacciamani_MD's tweet image. 👁️💻 Cystic renal masses are common incidental findings on imaging 💡AS may be appropriate if accurate stratification 💰#RenalCysts #ceUS studied for #activeSurveillance cost-effectiveness compared to CT & MRI 👉tinyurl.com/mcu32ucx
Cacciamani_MD's tweet image. 👁️💻 Cystic renal masses are common incidental findings on imaging 💡AS may be appropriate if accurate stratification 💰#RenalCysts #ceUS studied for #activeSurveillance cost-effectiveness compared to CT & MRI 👉tinyurl.com/mcu32ucx
Cacciamani_MD's tweet image. 👁️💻 Cystic renal masses are common incidental findings on imaging 💡AS may be appropriate if accurate stratification 💰#RenalCysts #ceUS studied for #activeSurveillance cost-effectiveness compared to CT & MRI 👉tinyurl.com/mcu32ucx
1
2
10
2
2K
ESUR_JN's profile picture. Junior Network - European Society of Urogenital Radiology
ESUR Junior Network
 @ESUR_JN
Jan 6

🎉 Kick off the New Year with ESUR JN’s 1st Starter Pack! 📚 This month, we spotlight AS of SRMs. Explore our suggested article on ESUR website! ✨ Make this festive Epiphany count with knowledge that matters. #ActiveSurveillance #SmallRenalMasses #ESURJN

ESUR_JN's tweet image. 🎉 Kick off the New Year with ESUR JN’s 1st Starter Pack! 📚 This month, we spotlight AS of SRMs. Explore our suggested article on ESUR website! ✨ Make this festive Epiphany count with knowledge that matters. #ActiveSurveillance #SmallRenalMasses #ESURJN
ESUR_JN's tweet image. 🎉 Kick off the New Year with ESUR JN’s 1st Starter Pack! 📚 This month, we spotlight AS of SRMs. Explore our suggested article on ESUR website! ✨ Make this festive Epiphany count with knowledge that matters. #ActiveSurveillance #SmallRenalMasses #ESURJN
ESUR_JN's tweet image. 🎉 Kick off the New Year with ESUR JN’s 1st Starter Pack! 📚 This month, we spotlight AS of SRMs. Explore our suggested article on ESUR website! ✨ Make this festive Epiphany count with knowledge that matters. #ActiveSurveillance #SmallRenalMasses #ESURJN
0
5
14
0
590
thyroidjournal's profile picture. ATA's official monthly journal, is peer-reviewed for topics ranging from the molecular biology of the thyroid gland to clinical management of thyroid disorders.
Thyroid Journal
 @thyroidjournal
Jun 26, 2023

With 30-yrs experience, Miyauchi et al. describe 3222 pts under #ActiveSurveillance for papillary #thyroid microcarcinoma, confirming favorable outcomes & long-term safety for <1cm #thyroidcancer #ThyroidJournal #medtwitter #endotwitter #PTC #thyroidectomy ow.ly/HNVB50OTWNX

thyroidjournal's tweet image. With 30-yrs experience, Miyauchi et al. describe 3222 pts under #ActiveSurveillance for papillary #thyroid microcarcinoma, confirming favorable outcomes &amp;amp; long-term safety for &amp;lt;1cm #thyroidcancer #ThyroidJournal #medtwitter #endotwitter #PTC #thyroidectomy ow.ly/HNVB50OTWNX
0
17
30
6
4K
ancan501c3's profile picture. Hi, we're AnCan 👋 We believe in advocacy, support, and education for all, no matter where you are, or what condition you have 💜 💚 Learn more and join us 👇
AnCan Foundation
 @ancan501c3
Nov 12

ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, & 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ

ancan501c3's tweet image. ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, &amp;amp; 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ
0
0
0
0
13
ancan501c3's profile picture. Hi, we're AnCan 👋 We believe in advocacy, support, and education for all, no matter where you are, or what condition you have 💜 💚 Learn more and join us 👇
AnCan Foundation
 @ancan501c3
Nov 5

ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, & 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ

ancan501c3's tweet image. ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, &amp;amp; 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ
0
0
0
0
12
ASPI_INTL's profile picture. ASPI is a patient-run international organization founded by men with prostate cancer (PCa) to support newly diagnosed men with low & intermediate grade PCa.
Active Surveillance Patients International
@ASPI_INTL
Nov 3

Major trials are reshaping prostate biopsy—a potential game changer for #ActiveSurveillance. Transrectal vs transperineal—which is safer and more accurate? Hear Drs. Hu, Lamb & Mian at ASPI’s free roundtable, Nov 22 (12–1:30 PM ET). Register 👉: aspatients.org/event/transper…

ASPI_INTL's tweet image. Major trials are reshaping prostate biopsy—a potential game changer for #ActiveSurveillance. Transrectal vs transperineal—which is safer and more accurate? Hear Drs. Hu, Lamb &amp;amp; Mian at ASPI’s free roundtable, Nov 22 (12–1:30 PM ET). Register 👉: aspatients.org/event/transper…
0
0
0
0
43
ancan501c3's profile picture. Hi, we're AnCan 👋 We believe in advocacy, support, and education for all, no matter where you are, or what condition you have 💜 💚 Learn more and join us 👇
AnCan Foundation
 @ancan501c3
Oct 22

ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, & 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ

ancan501c3's tweet image. ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, &amp;amp; 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ
0
0
0
0
11
GhiamAlireza's profile picture. Radiation Oncologist @UCIrvineHealth l Former Associate Prof @StanfordRadOnc & Assistant Prof @PennMedicine | AI | GU | Head & Neck | Oligomet | Palliative RT
Liam (Alireza) Ghiam, MD, MS 🇺🇸 🇨🇦
@GhiamAlireza
Oct 19

Lots of great discussion this weekend about #activesurveillance, GG2, grading, and MRI-targeted biopsy in #prostatecancer. Perfect time to revisit this study comparing multiparametric and biparametric MRI. 👇 jamanetwork.com/journals/jama/… #PRIME Trial: Prime example of using…

GhiamAlireza's tweet image. Lots of great discussion this weekend about #activesurveillance, GG2, grading, and MRI-targeted biopsy in #prostatecancer. Perfect time to revisit this study comparing multiparametric and biparametric MRI. 👇 jamanetwork.com/journals/jama/… #PRIME Trial: Prime example of using…
0
0
3
0
151
ASPI_INTL's profile picture. ASPI is a patient-run international organization founded by men with prostate cancer (PCa) to support newly diagnosed men with low & intermediate grade PCa.
Active Surveillance Patients International
@ASPI_INTL
Sep 29

Are bi-parametric MRIs ready to replace multiparametric MRI? 🤔 Join our Expert Panel + Q&A on Saturday, October 25th | 12–1:30 ET with Drs. Kasivisvanathan, Davenport & Pockros. 📌 Register: aspatients.org/event/are-bi-p… #ProstateCancer #MRI #ActiveSurveillance

ASPI_INTL's tweet image. Are bi-parametric MRIs ready to replace multiparametric MRI? 🤔 Join our Expert Panel + Q&amp;amp;A on Saturday, October 25th | 12–1:30 ET with Drs. Kasivisvanathan, Davenport &amp;amp; Pockros. 📌 Register: aspatients.org/event/are-bi-p… #ProstateCancer #MRI #ActiveSurveillance
ASPI_INTL's tweet image. Are bi-parametric MRIs ready to replace multiparametric MRI? 🤔 Join our Expert Panel + Q&amp;amp;A on Saturday, October 25th | 12–1:30 ET with Drs. Kasivisvanathan, Davenport &amp;amp; Pockros. 📌 Register: aspatients.org/event/are-bi-p… #ProstateCancer #MRI #ActiveSurveillance
ASPI_INTL's tweet image. Are bi-parametric MRIs ready to replace multiparametric MRI? 🤔 Join our Expert Panel + Q&amp;amp;A on Saturday, October 25th | 12–1:30 ET with Drs. Kasivisvanathan, Davenport &amp;amp; Pockros. 📌 Register: aspatients.org/event/are-bi-p… #ProstateCancer #MRI #ActiveSurveillance
ASPI_INTL's tweet image. Are bi-parametric MRIs ready to replace multiparametric MRI? 🤔 Join our Expert Panel + Q&amp;amp;A on Saturday, October 25th | 12–1:30 ET with Drs. Kasivisvanathan, Davenport &amp;amp; Pockros. 📌 Register: aspatients.org/event/are-bi-p… #ProstateCancer #MRI #ActiveSurveillance
0
0
0
0
47
ancan501c3's profile picture. Hi, we're AnCan 👋 We believe in advocacy, support, and education for all, no matter where you are, or what condition you have 💜 💚 Learn more and join us 👇
AnCan Foundation
 @ancan501c3
Sep 24

ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, & 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ

ancan501c3's tweet image. ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, &amp;amp; 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ
0
0
0
0
13
ancan501c3's profile picture. Hi, we're AnCan 👋 We believe in advocacy, support, and education for all, no matter where you are, or what condition you have 💜 💚 Learn more and join us 👇
AnCan Foundation
 @ancan501c3
Sep 17

ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, & 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ

ancan501c3's tweet image. ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, &amp;amp; 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ
0
0
0
0
11
dr_coops's profile picture. Urologic oncology & epi, focus on #prostatecancer @UCSFcancer @UCSFurology. GU Chief @SFVAMC. All views strictly personal. RT≠E. #🟦
Matt Cooperberg
@dr_coops
Sep 10

Why we still need to move past risk groups for #prostatecancer @nccn @AmerUrological @uroweb. The pt on the left is an easy candidate for #activesurveillance; the one on the right likely has metastatic disease.

dr_coops's tweet image. Why we still need to move past risk groups for #prostatecancer @nccn @AmerUrological @uroweb. The pt on the left is an easy candidate for #activesurveillance; the one on the right likely has metastatic disease.
10
13
66
14
8K
ancan501c3's profile picture. Hi, we're AnCan 👋 We believe in advocacy, support, and education for all, no matter where you are, or what condition you have 💜 💚 Learn more and join us 👇
AnCan Foundation
 @ancan501c3
Sep 10

ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, & 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ

ancan501c3's tweet image. ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, &amp;amp; 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ
0
1
1
0
98
perryjxu's profile picture. Assistant Professor of Urology at Northwestern University #endourologist #holep #pcnl #urs #bph #kidneystones
Perry Xu
 @perryjxu
Sep 9

Grateful to present our collaborative work showing that in modern day, prostates can grow close to 5% per year in volume on serial MRI for patients with GG1 prostate cancer. Don’t forget to surveil for BPH! #bph #activesurveillance @NM_Urology @Endo_Society #wcet2025

perryjxu's tweet image. Grateful to present our collaborative work showing that in modern day, prostates can grow close to 5% per year in volume on serial MRI for patients with GG1 prostate cancer. Don’t forget to surveil for BPH! #bph #activesurveillance @NM_Urology @Endo_Society #wcet2025
2
2
19
0
2K
ancan501c3's profile picture. Hi, we're AnCan 👋 We believe in advocacy, support, and education for all, no matter where you are, or what condition you have 💜 💚 Learn more and join us 👇
AnCan Foundation
 @ancan501c3
Sep 3

ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, & 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ

ancan501c3's tweet image. ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, &amp;amp; 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ
0
0
0
0
17
kagawa_urology's profile picture. This is the official account of Department of Urology, Faculty of medicine, Kagawa University. 香川大学医学部附属病院 泌尿器・副腎・腎移植外科の公式アカウントです。 #urology
Kagawa University Urology
 @kagawa_urology
Aug 31

Trends in active surveillance (AS) for prostate cancer in Japan 🇯🇵 🔹 More intermediate-risk (24.7% in 2023) 🔹 Aging AS population (↑75+ years) 🔹 Decline in brachytherapy use bit.ly/3JZ7fI3 #ProstateCancer #ActiveSurveillance #Urology

kagawa_urology's tweet card. These findings highlight a notable shift in the adoption of AS in Japan, with an increasing proportion of intermediate-risk and older patients. The rise in off protocol AS discontinuation underscores...
Temporal changes in the urologist's practice behaviour of active surveillance for prostate cancer:...
Source: pubmed.ncbi.nlm.nih.gov
1
1
2
0
61
ASPI_INTL's profile picture. ASPI is a patient-run international organization founded by men with prostate cancer (PCa) to support newly diagnosed men with low & intermediate grade PCa.
Active Surveillance Patients International
@ASPI_INTL
Aug 29

Missed it live? The replay is here! 🎥 Dr. Adam Kinnaird explains how micro-ultrasound compares to MRI for monitoring prostate cancer on Active Surveillance. Watch now: aspatients.org/meeting/micro-… #ProstateCancer #ActiveSurveillance

ASPI_INTL's tweet image. Missed it live? The replay is here! 🎥 Dr. Adam Kinnaird explains how micro-ultrasound compares to MRI for monitoring prostate cancer on Active Surveillance. Watch now: aspatients.org/meeting/micro-… #ProstateCancer #ActiveSurveillance
0
0
0
0
153
GUOncologyNow's profile picture. GU Oncology Now brings you the latest research and updates in #prostatecancer, #bladdercancer, #kidneycancer, and more in the genitourinary oncology sphere.
GU Oncology Now
 @GUOncologyNow
Aug 29

👉 #ActiveSurveillance—an underutilized alternative to primary intervention—was found to be non-inferior to primary intervention in the management of small #RenalMasses in patients with #RCC: buff.ly/3bYrS4E

GUOncologyNow's tweet image. 👉 #ActiveSurveillance—an underutilized alternative to primary intervention—was found to be non-inferior to primary intervention in the management of small #RenalMasses in patients with #RCC: buff.ly/3bYrS4E
0
0
0
0
219
ancan501c3's profile picture. Hi, we're AnCan 👋 We believe in advocacy, support, and education for all, no matter where you are, or what condition you have 💜 💚 Learn more and join us 👇
AnCan Foundation
 @ancan501c3
Aug 27

ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, & 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ

ancan501c3's tweet image. ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, &amp;amp; 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ
0
0
0
0
42
ancan501c3's profile picture. Hi, we're AnCan 👋 We believe in advocacy, support, and education for all, no matter where you are, or what condition you have 💜 💚 Learn more and join us 👇
AnCan Foundation
 @ancan501c3
Aug 20

ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, & 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ

ancan501c3's tweet image. ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, &amp;amp; 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ
0
0
0
0
20
ProstateUK's profile picture. 1 in 8 men will get prostate cancer. We work to give every man the power to navigate it. #ProstateCancerUK
Prostate Cancer UK
 @ProstateUK
Aug 19

Meet Michael 👋 He might look familiar from our new TV advert - and his connection is personal. He was diagnosed with #ProstateCancer in 2020 and was on #ActiveSurveillance until early 2024, when he underwent surgery. #MensHealth

ProstateUK's tweet image. Meet Michael 👋 He might look familiar from our new TV advert - and his connection is personal. He was diagnosed with #ProstateCancer in 2020 and was on #ActiveSurveillance until early 2024, when he underwent surgery. #MensHealth
1
3
25
0
2K
britishthyroid's profile picture. We're a patient organisation dedicated to providing evidence-based information & support, and funding research, to help people live better with thyroid disease.
BTF Thyroid
 @britishthyroid
Aug 15

Researchers from the University of Birmingham are inviting people with lived experience of thyroid cancer to complete a short, anonymous survey by 26 August 🔗tinyurl.com/3af7j5ax #ThyroidCancer #surgery #ActiveSurveillance

britishthyroid's tweet image. Researchers from the University of Birmingham are inviting people with lived experience of thyroid cancer to complete a short, anonymous survey by 26 August 🔗tinyurl.com/3af7j5ax #ThyroidCancer #surgery #ActiveSurveillance
0
4
7
0
527
dr_coops's profile picture. Urologic oncology & epi, focus on #prostatecancer @UCSFcancer @UCSFurology. GU Chief @SFVAMC. All views strictly personal. RT≠E. #🟦
Matt Cooperberg
@dr_coops
Sep 10

Why we still need to move past risk groups for #prostatecancer @nccn @AmerUrological @uroweb. The pt on the left is an easy candidate for #activesurveillance; the one on the right likely has metastatic disease.

dr_coops's tweet image. Why we still need to move past risk groups for #prostatecancer @nccn @AmerUrological @uroweb. The pt on the left is an easy candidate for #activesurveillance; the one on the right likely has metastatic disease.
10
13
66
14
8K
Nolazco_JI's profile picture. 👨🏽‍⚕️ SUO Urologic Oncology Fellow | @harvardmed 🏥 @BWHUrology @MGHUrology @DanaFarber 🌐 #Fulbright Scholar 👨🏽‍🎓 MMSCI Alumni @Harvard #UroSoMe 🇦🇷🇺🇲
José Ignacio Nolazco, MD, MMSc
 @Nolazco_JI
Jan 3, 2023

Editorial Commentary: Surgery: Urological Surgery 👉 𝐀𝐜𝐭𝐢𝐯𝐞 𝐬𝐮𝐫𝐯𝐞𝐢𝐥𝐥𝐚𝐧𝐜𝐞 𝐟𝐨𝐫 𝐜𝐨𝐦𝐩𝐥𝐞𝐱 𝐫𝐞𝐧𝐚𝐥 𝐜𝐲𝐬𝐭𝐬: 𝐢𝐬 𝐢𝐭 𝐭𝐢𝐦𝐞 𝐟𝐨𝐫 𝐈𝐈𝐈-𝐅 𝐚𝐧𝐝 𝐈𝐕-𝐅? PDF link: amj.amegroups.com/article/view/7… #activesurveillance #renalcysts #renalcancer #urology

Nolazco_JI's tweet image. Editorial Commentary: Surgery: Urological Surgery 👉 𝐀𝐜𝐭𝐢𝐯𝐞 𝐬𝐮𝐫𝐯𝐞𝐢𝐥𝐥𝐚𝐧𝐜𝐞 𝐟𝐨𝐫 𝐜𝐨𝐦𝐩𝐥𝐞𝐱 𝐫𝐞𝐧𝐚𝐥 𝐜𝐲𝐬𝐭𝐬: 𝐢𝐬 𝐢𝐭 𝐭𝐢𝐦𝐞 𝐟𝐨𝐫 𝐈𝐈𝐈-𝐅 𝐚𝐧𝐝 𝐈𝐕-𝐅? PDF link: amj.amegroups.com/article/view/7… #activesurveillance #renalcysts #renalcancer #urology
5
25
69
9
19K
dr_coops's profile picture. Urologic oncology & epi, focus on #prostatecancer @UCSFcancer @UCSFurology. GU Chief @SFVAMC. All views strictly personal. RT≠E. #🟦
Matt Cooperberg
@dr_coops
Mar 12, 2023

Histologic outcomes in #activesurveillance by baseline and change in MRI ⁦@mrsprostate⁩ #eau23

dr_coops's tweet image. Histologic outcomes in #activesurveillance by baseline and change in MRI ⁦@mrsprostate⁩ #eau23
dr_coops's tweet image. Histologic outcomes in #activesurveillance by baseline and change in MRI ⁦@mrsprostate⁩ #eau23
1
6
25
2
5K
dr_coops's profile picture. Urologic oncology & epi, focus on #prostatecancer @UCSFcancer @UCSFurology. GU Chief @SFVAMC. All views strictly personal. RT≠E. #🟦
Matt Cooperberg
@dr_coops
Mar 2, 2023

Trends and Variation in Use of #Activesurveillance for Low-risk #Prostatecancer, now out in @JAMANetworkOpen ja.ma/3SK4uuB. Data from over 20K men in the @AmerUrological #AQUARegistry: Nat'l rates of AS up from 26% to 60% since 2014, but variation remains extreme:

dr_coops's tweet image. Trends and Variation in Use of #Activesurveillance for Low-risk #Prostatecancer, now out in @JAMANetworkOpen ja.ma/3SK4uuB. Data from over 20K men in the @AmerUrological #AQUARegistry: Nat&apos;l rates of AS up from 26% to 60% since 2014, but variation remains extreme:
dr_coops's tweet image. Trends and Variation in Use of #Activesurveillance for Low-risk #Prostatecancer, now out in @JAMANetworkOpen ja.ma/3SK4uuB. Data from over 20K men in the @AmerUrological #AQUARegistry: Nat&apos;l rates of AS up from 26% to 60% since 2014, but variation remains extreme:
dr_coops's tweet image. Trends and Variation in Use of #Activesurveillance for Low-risk #Prostatecancer, now out in @JAMANetworkOpen ja.ma/3SK4uuB. Data from over 20K men in the @AmerUrological #AQUARegistry: Nat&apos;l rates of AS up from 26% to 60% since 2014, but variation remains extreme:
dr_coops's tweet image. Trends and Variation in Use of #Activesurveillance for Low-risk #Prostatecancer, now out in @JAMANetworkOpen ja.ma/3SK4uuB. Data from over 20K men in the @AmerUrological #AQUARegistry: Nat&apos;l rates of AS up from 26% to 60% since 2014, but variation remains extreme:
11
50
152
13
35K
dr_coops's profile picture. Urologic oncology & epi, focus on #prostatecancer @UCSFcancer @UCSFurology. GU Chief @SFVAMC. All views strictly personal. RT≠E. #🟦
Matt Cooperberg
@dr_coops
Jul 3

Great paper @EUplatinum confirming safety of #activesurveillance for #prostatecancer out to 25 years in the Göteborg-1 trial. dx.doi.org/10.1016/j.euru…

dr_coops's tweet image. Great paper @EUplatinum confirming safety of #activesurveillance for #prostatecancer out to 25 years in the Göteborg-1 trial. dx.doi.org/10.1016/j.euru…
2
23
92
21
6K
Adam_Weiner535's profile picture. @CedarsSinai + @UclaUrology @UroOnc ♋️🧬|Supporting editor @EUplatinum📝|Formerly: @NM_Urology @Uchipritzker @Yale ‘12| @abhita_reddy=No one can do it better❤️
Adam B. Weiner, MD
@Adam_Weiner535
Sep 27, 2023

Good to know! No MD has ever been successfully sued ⚖️ for promoting #activesurveillance for #prostatecancer (or any cancer) In fact, three lawsuits were related to "NOT" recommending AS @allenhomd @TimDaskivich @CedarsSinaiMed #PCSM @AnnalsofSurgery tinyurl.com/bdcm35np

Adam_Weiner535's tweet image. Good to know! No MD has ever been successfully sued ⚖️ for promoting #activesurveillance for #prostatecancer (or any cancer) In fact, three lawsuits were related to &quot;NOT&quot; recommending AS @allenhomd @TimDaskivich @CedarsSinaiMed #PCSM @AnnalsofSurgery tinyurl.com/bdcm35np
2
6
45
3
11K
DrAndrewLoblaw's profile picture. Head of GU, Prostate Ca researcher @Sunnybrook. Committed to a Cure in Your Lifetime, putting patients 1st, doing more for less. Tweets my own.
Dr. Andrew Loblaw
 @DrAndrewLoblaw
Jun 3

@RDC13ro does it again! @RSNA Resident and Fellow Roentgen Research Award for his work identifying favourable intermediate patients where #ActiveSurveillance is safe. N=1699, mFU 10.3y 🟰 freedom from Mets for men with GG1 or GG2 with APP4 <5% @UofTDRO @SahgalArjun @ldawsonmd

DrAndrewLoblaw's tweet image. @RDC13ro does it again! @RSNA Resident and Fellow Roentgen Research Award for his work identifying favourable intermediate patients where #ActiveSurveillance is safe. N=1699, mFU 10.3y 🟰 freedom from Mets for men with GG1 or GG2 with APP4 &amp;lt;5% @UofTDRO @SahgalArjun @ldawsonmd
1
3
19
2
1K
ASPI_INTL's profile picture. ASPI is a patient-run international organization founded by men with prostate cancer (PCa) to support newly diagnosed men with low & intermediate grade PCa.
Active Surveillance Patients International
@ASPI_INTL
Nov 3

Major trials are reshaping prostate biopsy—a potential game changer for #ActiveSurveillance. Transrectal vs transperineal—which is safer and more accurate? Hear Drs. Hu, Lamb & Mian at ASPI’s free roundtable, Nov 22 (12–1:30 PM ET). Register 👉: aspatients.org/event/transper…

ASPI_INTL's tweet image. Major trials are reshaping prostate biopsy—a potential game changer for #ActiveSurveillance. Transrectal vs transperineal—which is safer and more accurate? Hear Drs. Hu, Lamb &amp;amp; Mian at ASPI’s free roundtable, Nov 22 (12–1:30 PM ET). Register 👉: aspatients.org/event/transper…
0
0
0
0
43
RicBertolo's profile picture. Assistant Prof. of Urology @UniVerona || @ERUSRobotics, @SIU_Italia Research, @AgileGroupUro Member || @EAU_Uroonco Associate Editor || @Surgquest Urology Lead
𝙍𝙞𝙘𝙘𝙖𝙧𝙙𝙤 𝘽𝙚𝙧𝙩𝙤𝙡𝙤 MD PhD
 @RicBertolo
Jun 9, 2024

New study by our group published on @ejsotweets #PartialNephrectomy After a Period of #ActiveSurveillance: Are Perioperative and Pathology Outcomes Worsened Compared to Immediate Surgery? Read the #OpenAccess full text: 🔗 ejso.com/article/S0748-… Visual abstract below ⬇️

RicBertolo's tweet image. New study by our group published on @ejsotweets #PartialNephrectomy After a Period of #ActiveSurveillance: Are Perioperative and Pathology Outcomes Worsened Compared to Immediate Surgery? Read the #OpenAccess full text: 🔗 ejso.com/article/S0748-… Visual abstract below ⬇️
1
8
31
2
5K
ASPI_INTL's profile picture. ASPI is a patient-run international organization founded by men with prostate cancer (PCa) to support newly diagnosed men with low & intermediate grade PCa.
Active Surveillance Patients International
@ASPI_INTL
Sep 29

Are bi-parametric MRIs ready to replace multiparametric MRI? 🤔 Join our Expert Panel + Q&A on Saturday, October 25th | 12–1:30 ET with Drs. Kasivisvanathan, Davenport & Pockros. 📌 Register: aspatients.org/event/are-bi-p… #ProstateCancer #MRI #ActiveSurveillance

ASPI_INTL's tweet image. Are bi-parametric MRIs ready to replace multiparametric MRI? 🤔 Join our Expert Panel + Q&amp;amp;A on Saturday, October 25th | 12–1:30 ET with Drs. Kasivisvanathan, Davenport &amp;amp; Pockros. 📌 Register: aspatients.org/event/are-bi-p… #ProstateCancer #MRI #ActiveSurveillance
ASPI_INTL's tweet image. Are bi-parametric MRIs ready to replace multiparametric MRI? 🤔 Join our Expert Panel + Q&amp;amp;A on Saturday, October 25th | 12–1:30 ET with Drs. Kasivisvanathan, Davenport &amp;amp; Pockros. 📌 Register: aspatients.org/event/are-bi-p… #ProstateCancer #MRI #ActiveSurveillance
ASPI_INTL's tweet image. Are bi-parametric MRIs ready to replace multiparametric MRI? 🤔 Join our Expert Panel + Q&amp;amp;A on Saturday, October 25th | 12–1:30 ET with Drs. Kasivisvanathan, Davenport &amp;amp; Pockros. 📌 Register: aspatients.org/event/are-bi-p… #ProstateCancer #MRI #ActiveSurveillance
ASPI_INTL's tweet image. Are bi-parametric MRIs ready to replace multiparametric MRI? 🤔 Join our Expert Panel + Q&amp;amp;A on Saturday, October 25th | 12–1:30 ET with Drs. Kasivisvanathan, Davenport &amp;amp; Pockros. 📌 Register: aspatients.org/event/are-bi-p… #ProstateCancer #MRI #ActiveSurveillance
0
0
0
0
47
ancan501c3's profile picture. Hi, we're AnCan 👋 We believe in advocacy, support, and education for all, no matter where you are, or what condition you have 💜 💚 Learn more and join us 👇
AnCan Foundation
 @ancan501c3
Nov 12

ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, & 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ

ancan501c3's tweet image. ACTIVE SURVEILLANCE #prostatecancer - Learn from those who understand your position. Our group meets every 1st, 2nd, 3rd, &amp;amp; 4th Wednesday at 8 pm EST 👏 Join here ➡️ gotomeet.me/AnswerCancer #activesurveillance @UsTOOHQ
0
0
0
0
13
brookmans76's profile picture. Professor of Urology @LMU_Muenchen, SVP Therapeutic Area Head Urologic Oncology @AuraBiosciences - former VP R&D J&J - Sports Medicine 🚵‍♀️Passionate Cyclist
Sabine D. Brookman-May
 @brookmans76
Mar 12, 2023

How can we qualify men with GG2 #ProstateCancer for #ActiveSurveillance? Great talk by @dr_coops at #EAU23 outlining options to improve patient selection with clinical characteristics/CAPRA-Score -/+ additional genomic risk-classifiers (Decipher, Artera, Prolaris, Oncotype)

brookmans76's tweet image. How can we qualify men with GG2 #ProstateCancer for #ActiveSurveillance? Great talk by @dr_coops at #EAU23 outlining options to improve patient selection with clinical characteristics/CAPRA-Score -/+ additional genomic risk-classifiers (Decipher, Artera, Prolaris, Oncotype)
brookmans76's tweet image. How can we qualify men with GG2 #ProstateCancer for #ActiveSurveillance? Great talk by @dr_coops at #EAU23 outlining options to improve patient selection with clinical characteristics/CAPRA-Score -/+ additional genomic risk-classifiers (Decipher, Artera, Prolaris, Oncotype)
brookmans76's tweet image. How can we qualify men with GG2 #ProstateCancer for #ActiveSurveillance? Great talk by @dr_coops at #EAU23 outlining options to improve patient selection with clinical characteristics/CAPRA-Score -/+ additional genomic risk-classifiers (Decipher, Artera, Prolaris, Oncotype)
0
9
27
3
2K
brookmans76's profile picture. Professor of Urology @LMU_Muenchen, SVP Therapeutic Area Head Urologic Oncology @AuraBiosciences - former VP R&D J&J - Sports Medicine 🚵‍♀️Passionate Cyclist
Sabine D. Brookman-May
 @brookmans76
Oct 28, 2023

Excellent review/MA: non-surgical interventions 5ARI, ARSI, exercise in #ProstateCancer #ActiveSurveillance 👉Risk of bias↗️ no reliable conclusions (yet) 👉Adding some more concerns: biopsy detection bias ➡️impact on PFS, next treatment subjectivity, possible rebound (ENACT)👇

brookmans76's tweet image. Excellent review/MA: non-surgical interventions 5ARI, ARSI, exercise in #ProstateCancer #ActiveSurveillance 👉Risk of bias↗️ no reliable conclusions (yet) 👉Adding some more concerns: biopsy detection bias ➡️impact on PFS, next treatment subjectivity, possible rebound (ENACT)👇
brookmans76's tweet image. Excellent review/MA: non-surgical interventions 5ARI, ARSI, exercise in #ProstateCancer #ActiveSurveillance 👉Risk of bias↗️ no reliable conclusions (yet) 👉Adding some more concerns: biopsy detection bias ➡️impact on PFS, next treatment subjectivity, possible rebound (ENACT)👇
1
14
41
3
6K
MUSICUrology's profile picture. Michigan Urological Surgery Improvement Collaborative (MUSIC), is a community of urology practices - 46 within Michigan and 4 outside of MI. Funded by @BCBSM
MUSIC Urology
@MUSICUrology
May 9

Collaborative members discussed: 1. Who should be on #activesurveillance 2. Who should be LR v HR 3. How best to follow LR v HR 4. What else should we know about AS? What do you think? #Pca #QualityImprovement

MUSICUrology's tweet image. Collaborative members discussed: 1. Who should be on #activesurveillance 2. Who should be LR v HR 3. How best to follow LR v HR 4. What else should we know about AS? What do you think? #Pca #QualityImprovement
MUSICUrology's tweet image. Collaborative members discussed: 1. Who should be on #activesurveillance 2. Who should be LR v HR 3. How best to follow LR v HR 4. What else should we know about AS? What do you think? #Pca #QualityImprovement
MUSICUrology's tweet image. Collaborative members discussed: 1. Who should be on #activesurveillance 2. Who should be LR v HR 3. How best to follow LR v HR 4. What else should we know about AS? What do you think? #Pca #QualityImprovement
MUSICUrology's tweet image. Collaborative members discussed: 1. Who should be on #activesurveillance 2. Who should be LR v HR 3. How best to follow LR v HR 4. What else should we know about AS? What do you think? #Pca #QualityImprovement
0
2
8
0
842
Cacciamani_MD's profile picture. Assoc Prof @USC_Urology | Director of Lab @urology_AI | Chair @EAU_YAUroTech | PI @AI_PRISMA @CANGARU_check| Board @ESUI_uro @JUrology @UroAI_news | RT/RE≠E
Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺
@Cacciamani_MD
Feb 15, 2023

👁️💻 Cystic renal masses are common incidental findings on imaging 💡AS may be appropriate if accurate stratification 💰#RenalCysts #ceUS studied for #activeSurveillance cost-effectiveness compared to CT & MRI 👉tinyurl.com/mcu32ucx

Cacciamani_MD's tweet image. 👁️💻 Cystic renal masses are common incidental findings on imaging 💡AS may be appropriate if accurate stratification 💰#RenalCysts #ceUS studied for #activeSurveillance cost-effectiveness compared to CT &amp;amp; MRI 👉tinyurl.com/mcu32ucx
Cacciamani_MD's tweet image. 👁️💻 Cystic renal masses are common incidental findings on imaging 💡AS may be appropriate if accurate stratification 💰#RenalCysts #ceUS studied for #activeSurveillance cost-effectiveness compared to CT &amp;amp; MRI 👉tinyurl.com/mcu32ucx
Cacciamani_MD's tweet image. 👁️💻 Cystic renal masses are common incidental findings on imaging 💡AS may be appropriate if accurate stratification 💰#RenalCysts #ceUS studied for #activeSurveillance cost-effectiveness compared to CT &amp;amp; MRI 👉tinyurl.com/mcu32ucx
1
2
10
2
2K
thyroidjournal's profile picture. ATA's official monthly journal, is peer-reviewed for topics ranging from the molecular biology of the thyroid gland to clinical management of thyroid disorders.
Thyroid Journal
 @thyroidjournal
Jun 26, 2023

With 30-yrs experience, Miyauchi et al. describe 3222 pts under #ActiveSurveillance for papillary #thyroid microcarcinoma, confirming favorable outcomes & long-term safety for <1cm #thyroidcancer #ThyroidJournal #medtwitter #endotwitter #PTC #thyroidectomy ow.ly/HNVB50OTWNX

thyroidjournal's tweet image. With 30-yrs experience, Miyauchi et al. describe 3222 pts under #ActiveSurveillance for papillary #thyroid microcarcinoma, confirming favorable outcomes &amp;amp; long-term safety for &amp;lt;1cm #thyroidcancer #ThyroidJournal #medtwitter #endotwitter #PTC #thyroidectomy ow.ly/HNVB50OTWNX
0
17
30
6
4K
KariTikkinen's profile picture. Urology Prof @HelsinkiUni @paijatha @HUS_fi 🇫🇮| Clin Epi Prof @hei_mcmaster🇨🇦| Lead CLUE Working Group🗺️| Member @uroweb Scientific Office🇪🇺 #EBM
Kari Tikkinen
 @KariTikkinen
Feb 23, 2023

How many discontinue #ActiveSurveillance for low-grade #ProstateCancer? In a population-based study from Ontario 🇨🇦 the answer is about 50% at 5 years and about two thirds at 10 years Cancer-specific survival was 98% at 10 years auajournals.org/doi/epdf/10.10… #EBM @CanUrolAssoc

KariTikkinen's tweet image. How many discontinue #ActiveSurveillance for low-grade #ProstateCancer? In a population-based study from Ontario 🇨🇦 the answer is about 50% at 5 years and about two thirds at 10 years Cancer-specific survival was 98% at 10 years auajournals.org/doi/epdf/10.10… #EBM @CanUrolAssoc
3
15
49
5
22K
clinicalthyroid's profile picture. A journal of the @AmThyroidAssn. Covers the latest clinical #thyroid research & issues. Editor: @DoctorAngell | CT for the Public: @thyroidfriends
Clinical Thyroidology
 @clinicalthyroid
Oct 5

Read the Latest Open Access in October! What happens to #PapillaryThyroidMicrocarcinoma under #ActiveSurveillance during #pregnancy? Commentary by Drs. @DrRoweEndo & Boelaert on data pub'd in @thyroidjournal ow.ly/F57X50X6j1o #thyroidcancer #thyroid #medtwitter #endotwitter

clinicalthyroid's tweet image. Read the Latest Open Access in October! What happens to #PapillaryThyroidMicrocarcinoma under #ActiveSurveillance during #pregnancy? Commentary by Drs. @DrRoweEndo &amp;amp; Boelaert on data pub&apos;d in @thyroidjournal ow.ly/F57X50X6j1o #thyroidcancer #thyroid #medtwitter #endotwitter
0
0
6
1
469

Something went wrong.


Something went wrong.


United States Trends